Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
X Financial A ADR | XYF | Apr 29, 2024 | 3.90 | +1.40 |
X3 Holdings | XTKG | Apr 29, 2024 | 0.63 | 0.00 |
X4 Pharmaceuticals | XFOR | Apr 29, 2024 | 1.09 | -6.44 |
XAI Octagon Floating Rate & Alternative Income Term Trust | XFLT | Apr 29, 2024 | 7.03 | +0.14 |
XAI Octagon Floating Rate & Alternative Income Term Trust 20 | XFLT-A | Apr 29, 2024 | 24.50 | -0.43 |
XBiotech | XBIT | Apr 29, 2024 | 7.76 | -1.40 |
XBP Europe | XBP | Apr 29, 2024 | 1.50 | 0.00 |
Xcel Brands | XELB | Apr 29, 2024 | 0.75 | +9.80 |
Xcel Energy | XEL | Apr 29, 2024 | 54.48 | +0.96 |
Xencor | XNCR | Apr 29, 2024 | 21.07 | +5.46 |
Xenetic Biosciences | XBIO | Apr 29, 2024 | 4.00 | -2.20 |
Xenia Hotels & Resorts | XHR | Apr 29, 2024 | 14.11 | -0.14 |
Xenon Pharmaceuticals | XENE | Apr 29, 2024 | 42.73 | +5.51 |
Xeris Biopharma | XERS | Apr 29, 2024 | 1.75 | 0.00 |
Xerox | XRX | Apr 29, 2024 | 13.86 | -1.00 |
XIAO-I ADR | AIXI | Apr 29, 2024 | 1.30 | +1.56 |
Xilio Therapeutics | XLO | Apr 29, 2024 | 1.04 | -4.59 |
Xinyuan Real Estate ADR | XIN | Apr 29, 2024 | 2.72 | 0.00 |
XOMA | XOMA | Apr 29, 2024 | 26.50 | +4.29 |
XOMA A Pref | XOMAP | Apr 29, 2024 | 25.06 | +0.36 |
XOMA B Pref | XOMAO | Apr 29, 2024 | 24.89 | -0.32 |
Xometry A | XMTR | Apr 29, 2024 | 17.66 | +0.74 |
XORTX Therapeutics | XRTX | Apr 29, 2024 | 2.65 | -9.73 |
Xos | XOS | Apr 29, 2024 | 7.35 | -2.78 |
XP A | XP | Apr 29, 2024 | 21.42 | +1.71 |
XPEL | XPEL | Apr 29, 2024 | 54.41 | -0.60 |
XPeng A ADR | XPEV | Apr 29, 2024 | 8.10 | +3.32 |
Xperi | XPER | Apr 29, 2024 | 10.73 | +7.84 |
XPO Logistics | XPO | Apr 29, 2024 | 110.72 | -0.16 |
Xponential Fitness A | XPOF | Apr 29, 2024 | 13.00 | +1.48 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.